Literature DB >> 29507484

Impact of the Spinal Instability Neoplastic Score on Surgical Referral Patterns and Outcomes.

M Dosani1, S Lucas2, J Wong1, L Weir1, S Lomas1, C Cumayas1, C Fisher3, S Tyldesley1.   

Abstract

BACKGROUND: The Spinal Instability Neoplastic Score (sins) was developed to identify patients with spinal metastases who may benefit from surgical consultation. We aimed to assess the distribution of sins in a population-based cohort of patients undergoing palliative spine radiotherapy (rt) and referral rates to spinal surgery pre-rt. Secondary outcomes included referral to a spine surgeon post-rt, overall survival, maintenance of ambulation, need for re-intervention, and presence of spinal adverse events.
METHODS: We retrospectively reviewed ct simulation scans and charts of consecutive patients receiving palliative spine rt between 2012 and 2013. Data were analyzed using Student's t-test, Chi-squared, Fisher's exact, and Kaplan-Meier log-rank tests. Patients were stratified into low (<7) and high (≥7) sins groups.
RESULTS: We included 195 patients with a follow-up of 6.1 months. The median sins was 7. The score was 0 to 6 (low, no referral recommended), 7 to 12 (intermediate, consider referral), and 13 to 18 (high, referral suggested) in 34%, 59%, and 7% of patients, respectively. Eleven patients had pre-rt referral to spine surgery, with a surgery performed in 0 of 1 patient with sins 0 to 6, 1 of 7 with sins 7 to 12, and 1 of 3 with sins 13 to 18. Seven patients were referred to a surgeon post-rt with salvage surgery performed in two of those patients. Primary and secondary outcomes did not differ between low and high sins groups.
CONCLUSION: Higher sins was associated with pre-rt referral to a spine surgeon, but most patients with high sins were not referred. Higher sins was not associated with shorter survival or worse outcome following rt.

Entities:  

Keywords:  Palliative radiotherapy; radiation; spinal instability neoplastic score; spinal metastases; spinal surgery; spine radiotherapy

Year:  2018        PMID: 29507484      PMCID: PMC5832277          DOI: 10.3747/co.25.3835

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  17 in total

1.  The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.

Authors:  Edward Chow; Amanda Hird; Galina Velikova; Colin Johnson; Linda Dewolf; Andrea Bezjak; Jackson Wu; Jesmin Shafiq; Orhan Sezer; Dimitrios Kardamakis; Yvette van der Linden; Brigette Ma; Monica Castro; Palmira Foro Arnalot; Sam Ahmedzai; Mark Clemons; Peter Hoskin; Albert Yee; Michael Brundage; Andrew Bottomley
Journal:  Eur J Cancer       Date:  2008-12-25       Impact factor: 9.162

2.  Predicting life expectancy in patients with metastatic cancer receiving palliative radiotherapy: the TEACHH model.

Authors:  Monica S Krishnan; Zachary Epstein-Peterson; Yu-Hui Chen; Yolanda D Tseng; Alexi A Wright; Jennifer S Temel; Paul Catalano; Tracy A Balboni
Journal:  Cancer       Date:  2013-10-02       Impact factor: 6.860

3.  Reliability of the spinal instability neoplastic scale among radiologists: an assessment of instability secondary to spinal metastases.

Authors:  Charles G Fisher; Anne L Versteeg; Rowan Schouten; Stefano Boriani; Peter P Varga; Laurence D Rhines; Manraj K S Heran; Norio Kawahara; Daryl Fourney; Jeremy J Reynolds; Michael G Fehlings; Ziya L Gokaslan
Journal:  AJR Am J Roentgenol       Date:  2014-10       Impact factor: 3.959

4.  Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group.

Authors:  Daryl R Fourney; Evan M Frangou; Timothy C Ryken; Christian P Dipaola; Christopher I Shaffrey; Sigurd H Berven; Mark H Bilsky; James S Harrop; Michael G Fehlings; Stefano Boriani; Dean Chou; Meic H Schmidt; David W Polly; Roberto Biagini; Shane Burch; Mark B Dekutoski; Aruna Ganju; Peter C Gerszten; Ziya L Gokaslan; Michael W Groff; Norbert J Liebsch; Ehud Mendel; Scott H Okuno; Shreyaskumar Patel; Laurence D Rhines; Peter S Rose; Daniel M Sciubba; Narayan Sundaresan; Katsuro Tomita; Peter P Varga; Luiz R Vialle; Frank D Vrionis; Yoshiya Yamada; Charles G Fisher
Journal:  J Clin Oncol       Date:  2011-06-27       Impact factor: 44.544

Review 5.  Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group.

Authors:  D Andrew Loblaw; James Perry; Alexandra Chambers; Normand J Laperriere
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

Review 6.  A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group.

Authors:  Charles G Fisher; Christian P DiPaola; Timothy C Ryken; Mark H Bilsky; Christopher I Shaffrey; Sigurd H Berven; James S Harrop; Michael G Fehlings; Stefano Boriani; Dean Chou; Meic H Schmidt; David W Polly; Roberto Biagini; Shane Burch; Mark B Dekutoski; Aruna Ganju; Peter C Gerszten; Ziya L Gokaslan; Michael W Groff; Norbert J Liebsch; Ehud Mendel; Scott H Okuno; Shreyaskumar Patel; Laurence D Rhines; Peter S Rose; Daniel M Sciubba; Narayan Sundaresan; Katsuro Tomita; Peter P Varga; Luiz R Vialle; Frank D Vrionis; Yoshiya Yamada; Daryl R Fourney
Journal:  Spine (Phila Pa 1976)       Date:  2010-10-15       Impact factor: 3.468

7.  Prospective Evaluation of the Relationship Between Mechanical Stability and Response to Palliative Radiotherapy for Symptomatic Spinal Metastases.

Authors:  Joanne M van der Velden; Anne L Versteeg; Helena M Verkooijen; Charles G Fisher; Edward Chow; F Cumhur Oner; Marco van Vulpen; Lorna Weir; Jorrit-Jan Verlaan
Journal:  Oncologist       Date:  2017-05-03

8.  Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score.

Authors:  Arjun Sahgal; Eshetu G Atenafu; Sam Chao; Ameen Al-Omair; Nicholas Boehling; Ehsan H Balagamwala; Marcelo Cunha; Isabelle Thibault; Lilyana Angelov; Paul Brown; John Suh; Laurence D Rhines; Michael G Fehlings; Eric Chang
Journal:  J Clin Oncol       Date:  2013-08-19       Impact factor: 44.544

9.  The Effect of Introducing the Spinal Instability Neoplastic Score in Routine Clinical Practice for Patients With Spinal Metastases.

Authors:  Anne L Versteeg; Joanne M van der Velden; Helena M Verkooijen; Marco van Vulpen; F Cumhur Oner; Charles G Fisher; Jorrit-Jan Verlaan
Journal:  Oncologist       Date:  2015-12-14

10.  Spinal instability as defined by the spinal instability neoplastic score is associated with radiotherapy failure in metastatic spinal disease.

Authors:  Merel Huisman; Joanne M van der Velden; Marco van Vulpen; Maurice A A J van den Bosch; Edward Chow; F Cumhur Öner; Albert Yee; Helena M Verkooijen; Jorrit-Jan Verlaan
Journal:  Spine J       Date:  2014-04-04       Impact factor: 4.166

View more
  3 in total

Review 1.  Manifestations of radiation toxicity in the head, neck, and spine: An image-based review.

Authors:  Carrie M Carr; John C Benson; David R DeLone; Felix E Diehn; Dong K Kim; Daniel Ma; Alex A Nagelschneider; Ajay A Madhavan; Derek R Johnson
Journal:  Neuroradiol J       Date:  2022-05-01

2.  Impact of Spinal Instrumentation on Neurological Outcome in Patients with Intermediate Spinal Instability Neoplastic Score (SINS).

Authors:  Moritz Lenschow; Maximilian Lenz; Niklas von Spreckelsen; Julian Ossmann; Johanna Meyer; Julia Keßling; Lukas Nadjiri; Sergej Telentschak; Kourosh Zarghooni; Peter Knöll; Moritz Perrech; Eren Celik; Max Scheyerer; Volker Neuschmelting
Journal:  Cancers (Basel)       Date:  2022-04-27       Impact factor: 6.575

3.  Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients.

Authors:  Alexander Rühle; Verlaine Ange Nya Yompang; Simon K B Spohn; Raluca Stoian; Constantinos Zamboglou; Eleni Gkika; Anca-Ligia Grosu; Nils H Nicolay; Tanja Sprave
Journal:  Radiat Oncol       Date:  2022-09-07       Impact factor: 4.309

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.